Garnet Global Consultants LLP

Our Expertise

Research

Pharma Solutions

GGC's research and advocacy work is not just about generating evidence and conducting surveys. It's about making a tangible impact on healthcare outcomes. Our work informs programmes, policies, and strategies leading to improved care and accessibility and thus better health outcomes.

Pharma Solutions

GGC provide multiple solutions for pharma industry, including economic cost analysis, pricing, real-world evidence transforming diverse real-world data into strategic intelligence, market research to introduce new healthcare products and technologies, data-driven insights to optimize market access, and stakeholder engagement for lasting success.

PPP Transaction Advisory

We advise IDBs, governments, and commercial healthcare providers on end-to-end health PPP projects, including concept note development, pre-feasibility analysis, feasibility analysis, and procurement and contracting of service providers. Governments and development partners can utilise our technical assistance to select a private healthcare provider for government patients, and private developers can engage us as consultants to review their bids for PPP projects.

Digital Health and AI

PPP Transaction Advisory

This year, we are testing tech-driven service delivery approaches to make chronic diseases like cancer more affordable and accessible. Innovative digital technologies like AI-driven diagnostics, telemedicine, remote monitoring, and data-driven care coordination will expedite treatment paths, decrease inefficiencies, and minimise patient costs. Our strategy breaks geographical and financial obstacles to provide high-quality treatment to underrepresented people. Our patient-centric solutions will give people seamless access to fast, tailored, and cost-effective healthcare, boosting outcomes and patient experience.

Checkout the latest Updates

GGC received the Best Research Paper Award at SASH 2024

We earned the Best Paper Award at SASH 2024 for our research on India's diagnostic PPP scenario. This report provides a comprehensive analysis of public-private partnership arrangements in India's laboratory and imaging sectors. This study contributed to a better understanding of the many PPP models that exist in India. The findings of this study prompted us to make recommendations based on our landscape evaluations of various models, enablers, and barriers. These guidelines will assist programme managers in deciding between several models for optimal implementation.

GGC spoke at the "Vision for Malta's Future" conference in Malta

The Maltese government encouraged us to share our healthcare PPP expertise, specifically service contracts or small PPPs with significant impact and low investment. We discussed how PPP engagements benefit the private sector, the risks it must manage, how to make the partnership work over the life of the contract, and dispute resolution solutions. WAPPP deserves our gratitude for this opportunity. We believe PPPs, especially in Malta's health sector, will succeed. We are confident that MSPP, Malta's government PPP agency, will help the public and private sectors build PPP projects in this lovely country.